cefuroxime has been researched along with Neuroleptic Malignant Syndrome in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Neuroleptic Malignant Syndrome: A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neuroleptic malignant syndrome is an uncommon but potentially fatal side effect of antipsychotic drug treatment." | 1.35 | Infections as complications of neuroleptic malignant syndrome. ( Bilanakis, N; Kalampokis, G; Peritogiannis, V, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilanakis, N | 1 |
| Peritogiannis, V | 1 |
| Kalampokis, G | 1 |
1 other study available for cefuroxime and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
Infections as complications of neuroleptic malignant syndrome.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antipsychotic Agents; Cefuroxim | 2009 |